BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20304347)

  • 1. Perioperative chronic use of statins and the risk of muscle complaints in patients undergoing knee and hip endoprosthesis surgery.
    Laisalmi-Kokki M; Tolonen K; Miettinen H; Kokki H
    J Clin Anesth; 2010 Mar; 22(2):81-7. PubMed ID: 20304347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of succinylcholine administration to patients using statins.
    Turan A; Mendoza ML; Gupta S; You J; Gottlieb A; Chu W; Saager L; Sessler DI
    Anesthesiology; 2011 Jul; 115(1):28-35. PubMed ID: 21606827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there clinical benefit to routine enzyme testing of patients on statins?
    Elhayany A; Mishaal RA; Vinker S
    Expert Opin Drug Saf; 2012 Mar; 11(2):185-90. PubMed ID: 22088166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries.
    Chaipichit N; Krska J; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2015 Apr; 37(2):355-64. PubMed ID: 25630895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle symptoms associated with statins: a series of twenty patients.
    Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting.
    Smith CC; Bernstein LI; Davis RB; Rind DM; Shmerling RH
    Arch Intern Med; 2003 Mar; 163(6):688-92. PubMed ID: 12639201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insight into statin use and its association with muscular side effects in clinical practice.
    Farcas A; Bucsa C; Leucuta D; Mogosan C; Bojita M; Dumitrascu D
    Rom J Intern Med; 2015; 53(2):153-60. PubMed ID: 26402985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing statin-induced muscle toxicity in a lipid clinic.
    Blaier O; Lishner M; Elis A
    J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dosage of cyclosporine induces myopathy with increased seru creatine kinase in an elderly patient on chronic statin therapy.
    Mo L; He J; Yue Q; Dong B; Huang X
    J Clin Pharm Ther; 2015 Apr; 40(2):245-8. PubMed ID: 25512016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
    Shanahan RL; Kerzee JA; Sandhoff BG; Carroll NM; Merenich JA
    Pharmacotherapy; 2005 Mar; 25(3):345-51. PubMed ID: 15843281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular symptoms and elevated creatine kinase after statin withdrawal.
    Echaniz-Laguna A; Mohr M; Tranchant C
    N Engl J Med; 2010 Feb; 362(6):564-5. PubMed ID: 20147729
    [No Abstract]   [Full Text] [Related]  

  • 15. Low plasma vitamin D levels and muscle-related adverse effects in statin users.
    Eisen A; Lev E; Iakobishvilli Z; Porter A; Brosh D; Hasdai D; Mager A
    Isr Med Assoc J; 2014 Jan; 16(1):42-5. PubMed ID: 24575504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin safety: lessons from new drug applications for marketed statins.
    Jacobson TA
    Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?
    Cornier MA; Eckel RH
    Curr Atheroscler Rep; 2015; 17(2):475. PubMed ID: 25432858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin intolerance.
    Ahmad Z
    Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in serum aspartate and alanine aminotransferase, lactate dehydrogenase, gamma-glutamyltransferase and creatine kinase activities and the myoglobin level during hemodialysis].
    Starzyk J; Kowalski D
    Wiad Lek; 1988 Oct; 41(20):1357-60. PubMed ID: 2907702
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.